Pfizer latest to test gene therapy for Duchenne muscular dystrophy – STAT
STAT |
Pfizer latest to test gene therapy for Duchenne muscular dystrophy
STAT fizer (PFE 1) has begun its first human trials 2 of a gene therapy to treat Duchenne muscular dystrophy, following two other companies that have launched trials and one treatment for the disease in recent years. The first patient received the … |
